Your browser doesn't support javascript.
loading
Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K.
Han, Fei; Zhang, Long; Zhang, Suxia; Zhou, Hong; Yi, Xianghua.
Afiliação
  • Han F; Department of Pathology, Shanghai Tongji Hospital Affiliated to Shanghai Tongji University 389 Xincun Rd, Shanghai 200065, China ; Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University 241 West Huaihai Rd, Shanghai 200030, China.
  • Zhang L; Department of Pathology, Shanghai Tongji Hospital Affiliated to Shanghai Tongji University 389 Xincun Rd, Shanghai 200065, China.
  • Zhang S; Department of Pathology, Shanghai Tongji Hospital Affiliated to Shanghai Tongji University 389 Xincun Rd, Shanghai 200065, China.
  • Zhou H; Department of Pathology, Shanghai Nanxiang Hospital 495 Zhonghe Rd, Jiading District, Shanghai, China.
  • Yi X; Department of Pathology, Shanghai Tongji Hospital Affiliated to Shanghai Tongji University 389 Xincun Rd, Shanghai 200065, China.
Int J Clin Exp Pathol ; 8(5): 5896-901, 2015.
Article em En | MEDLINE | ID: mdl-26191315
ABSTRACT
Warthin-Like tumor of the thyroid is a recently described rare variant of papillary thyroid cancer. The distinct histological feature of this variant is papillary architecture lining oncocytic epithelial cells with nuclear characteristics of papillary carcinoma, accompanied by prominent lymphocytic infiltration in the papillary stalks. Here, we present a case of occult Warthin-like papillary thyroid carcinoma, 0.5-cm in maximum dimension, underwent left thyroid lobectomy in a 65 years old Chinese woman. In this case, there was no extrathyroid extension, vascular invasion and lymphatic metastasis, as well as no complication of lymphocytic thyroiditis. Immunohistochemistry staining revealed that the tumor cells were positive for Leu-M1, HBME-1, 34ßE12, and MIB-1 labeling index was low. RET/PTC expression was absent in tumor cells. Furthermore, activated point mutations of BRAF V600E and V600K were concurrently detected by DNA sequencing. Further studies are needed to elucidate the prevalence and role of BRAF(V600K) mutation in papillary thyroid carcinoma, and long-term follow-up for the patient is needed to clarify the biological behavior of this variant with dual BRAF mutations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Papilar / Adenolinfoma / Biomarcadores Tumorais / Mutação Puntual / Adenoma Oxífilo / Proteínas Proto-Oncogênicas B-raf Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Papilar / Adenolinfoma / Biomarcadores Tumorais / Mutação Puntual / Adenoma Oxífilo / Proteínas Proto-Oncogênicas B-raf Idioma: En Ano de publicação: 2015 Tipo de documento: Article